发明名称 Composition for inducing proliferation or accumulation of regulatory T cells
摘要 It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells (Treg cells) induced by from these bacteria suppressed proliferation of effector T-cells. From these findings, the present inventors found that the use of bacteria belonging to the genus Clostridium or a physiologically active substance derived therefrom made it possible to induce proliferation or accumulation of regulatory T cells (Treg cells), and further to suppress immune functions.
申请公布号 US9433652(B2) 申请公布日期 2016.09.06
申请号 US201414492850 申请日期 2014.09.22
申请人 The University of Tokyo 发明人 Honda Kenya;Atarashi Koji;Itoh Kikuji;Tanoue Takeshi
分类号 A61K35/74;A61K35/742;A61K45/06;G01N33/50;A61K45/00;A01K67/027;C12Q1/68;A61K9/00;A61K35/00 主分类号 A61K35/74
代理机构 Wolf, Greenfield & Sacks, P.C. 代理人 Wolf, Greenfield & Sacks, P.C.
主权项 1. A method of treating a human subject having an infectious disease, an autoimmune disease, or an allergic disease, the method comprising administering a pharmaceutical composition comprising a purified bacterial mixture of at least two live bacterial strains belonging to Clostridium clusters IV and/or XIVa to the human subject, wherein the bacterial strains are spore-forming bacteria and are isolated from a human.
地址 Tokyo JP